<DOC>
	<DOC>NCT01357538</DOC>
	<brief_summary>This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.</brief_summary>
	<brief_title>Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis</brief_title>
	<detailed_description>Reduction of signs and symptoms of blepharitis</detailed_description>
	<mesh_term>Signs and Symptoms</mesh_term>
	<mesh_term>Blepharitis</mesh_term>
	<criteria>written informed consent ambulatory male and female patients 18 years of age or older summarised score of signs and symptoms of blepharitis of 15 or more at baseline different ocular conditions different system conditions several concomitant medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Bibrocathol</keyword>
	<keyword>eye ointment</keyword>
	<keyword>blepharitis</keyword>
	<keyword>eye lid</keyword>
</DOC>